Latest Product Validation News

Advanced Braking Technology increased Q1 FY27 product sales by 8.3% and ended September with $7.3 million in bank cash. The mining safety company also moved BRAKEiQ closer to CAS Level 9 certification, although the quarter produced a small loss before tax.

Titomic has converted a semiconductor manufacturing validation run into full-rate production, with revenue expected to reach approximately EUR 0.9 million in 2027. The company says the program could rise to about EUR 2.0 million in 2028, although customer and contract details remain undisclosed.

Impact Minerals’ 50%-owned Alluminous project reveals a strong financial case for a staged US high purity alumina plant, projecting a post-tax NPV₈ of A$518 million and a 42.3% IRR under a modular development approach.

Phoslock Environmental Technologies has advanced a new range of lanthanum-enhanced phosphorus-binding products showing up to four times the capacity of current offerings, with pilot and manufacturing tests confirming strong performance and low lanthanum release. Field trials are underway, aiming for commercial sales in 2027.

Audeara Limited delivered record FY26 revenue of $4.45 million, driven by a 45% surge in Australian wholesale sales and progress in AI audio licensing with OPTEK Microelectronics. The company narrowed its loss and advanced Auracast deployments across retirement villages and education sectors.

Wide Open Agriculture cut its loss to $3.64 million in FY2026 as it pivots from owning manufacturing to a capital-light contract model, while securing global commercial traction for its lupin-based ingredients.

Audeara has reached a key milestone as its chip-level AI licensing partnership with Optek enters commercial production, receiving initial purchase orders worth about A$31,000. This validates Audeara’s scalable fee-per-chip licensing model and sets the stage for broader applications in audio and hearing health.

IperionX has won up to US$6.6 million from the US Department of War to scale production of ballistic-grade titanium plate and military components, aiming to reduce reliance on imports and strengthen domestic supply chains.

Vitrafy Life Sciences has teamed up with Vitalant Innovation Center to tackle the impending gap in red blood cell cryopreservation technology in the US, aiming to replace soon-to-be-discontinued legacy methods and potentially expand into other blood products.

Anteris Technologies reported a $22.9 million net loss in Q1 2026 but bolstered its cash position to $283 million following a $320 million capital raise. The company is scaling manufacturing and clinical activities for its DurAVR transcatheter heart valve, with US patient enrolment now underway in the pivotal PARADIGM Trial.

Green360 Technologies has landed its first named commercial customer for Eco-Clay, signing a non-binding MOU with Holcim Australia to supply up to 4,800 tonnes over 12 months, marking a key step in commercialising its low-carbon cement replacement.

Merino & Co. reported Q3 FY26 revenue of A$441,558 with new domestic and China purchase orders supporting its growth strategy, while cash reserves fell to A$654,282 due to investments in production and marketing.